Abstract
Disease-causing polyalanine (PA) expansion mutations have been identified in nine genes, eight of which encode transcription factors (TFs) with important roles in development. In vitro and cell overexpression studies have shown that expanded PA tracts result in protein misfolding and the formation of aggregates. This feature of PA proteins is reminiscent of the related polyglutamine (PQ) disease proteins, which have been shown to cause disease via a gain-of-function (GOF) mechanism. However, in sharp contrast to PQ disorders, the disease phenotypes associated with PA mutations are more consistent with a LOF and/or mild GOF mechanism, suggesting that their molecular pathology is inherently different to PQ disorders. Elucidating the cellular impact of PA mutations in vivo has been difficult to address as, unlike the late-onset polyglutamine disorders, all PA disorders associated with TF gene mutations are congenital. However, in recent years, significant advances have been made through the analysis of engineered (knock-in) and spontaneous PA mouse models. Here we review these recent findings and propose an updated model of the molecular and cellular mechanism of PA disorders that incorporates both LOF and GOF features.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Pieretti M, Zhang FP, Fu YH, Warren ST, Oostra BA, Caskey CT, Nelson DL (1991) Absence of expression of the FMR-1 gene in fragile X syndrome. Cell 66(4):817–822. doi:0092-8674(91)90125-I [pii]
Sutcliffe JS, Nelson DL, Zhang F, Pieretti M, Caskey CT, Saxe D, Warren ST (1992) DNA methylation represses FMR-1 transcription in fragile X syndrome. Hum Mol Genet 1(6):397–400
Zu T, Gibbens B, Doty NS, Gomes-Pereira M, Huguet A, Stone MD, Margolis J, Peterson M, Markowski TW, Ingram MA, Nan Z, Forster C, Low WC, Schoser B, Somia NV, Clark HB, Schmechel S, Bitterman PB, Gourdon G, Swanson MS, Moseley M, Ranum LP (2011) Non-ATG-initiated translation directed by microsatellite expansions. Proc Natl Acad Sci USA 108(1):260–265. doi:1013343108 [pii] 10.1073/pnas.1013343108
Bauer PO, Nukina N (2009) The pathogenic mechanisms of polyglutamine diseases and current therapeutic strategies. J Neurochem 110(6):1737–1765. doi:JNC6302 [pii] 10.1111/j.1471-4159.2009.06302.x
Cocquempot O, Brault V, Babinet C, Herault Y (2009) Fork stalling and template switching as a mechanism for polyalanine tract expansion affecting the DYC mutant of HOXD13, a new murine model of synpolydactyly. Genetics 183(1):23–30
Trochet D, de Pontual L, Keren B, Munnich A, Vekemans M, Lyonnet S, Amiel J (2007) Polyalanine expansions might not result from unequal crossing-over. Hum Mutat 28(10):1043–1044
Muragaki Y, Mundlos S, Upton J, Olsen BR (1996) Altered growth and branching patterns in synpolydactyly caused by mutations in HOXD13. Science 272(5261):548–551
Brison N, Tylzanowski P, Debeer P (2011) Limb skeletal malformations—what the HOX is going on? Eur J Med Genet 55(1):1–7. doi:S1769-7212(11)00073-5 [pii] 10.1016/j.ejmg.2011.06.003
Goodman FR, Mundlos S, Muragaki Y, Donnai D, Giovannucci-Uzielli ML, Lapi E, Majewski F, McGaughran J, McKeown C, Reardon W, Upton J, Winter RM, Olsen BR, Scambler PJ (1997) Synpolydactyly phenotypes correlate with size of expansions in HOXD13 polyalanine tract. Proc Natl Acad Sci USA 94(14):7458–7463
Debeer P, Bacchelli C, Scambler PJ, De Smet L, Fryns JP, Goodman FR (2002) Severe digital abnormalities in a patient heterozygous for both a novel missense mutation in HOXD13 and a polyalanine tract expansion in HOXA13. J Med Genet 39(11):852–856
Innis JW, Mortlock D, Chen Z, Ludwig M, Williams ME, Williams TM, Doyle CD, Shao Z, Glynn M, Mikulic D, Lehmann K, Mundlos S, Utsch B (2004) Polyalanine expansion in HOXA13: three new affected families and the molecular consequences in a mouse model. Hum Mol Genet 13(22):2841–2851
Utsch B, Becker K, Brock D, Lentze MJ, Bidlingmaier F, Ludwig M (2002) A novel stable polyalanine [poly(A)] expansion in the HOXA13 gene associated with hand-foot-genital syndrome: proper function of poly(A)-harbouring transcription factors depends on a critical repeat length? Hum Genet 110(5):488–494. doi:10.1007/s00439-002-0712-8
Miura H, Yanazawa M, Kato K, Kitamura K (1997) Expression of a novel aristaless related homeobox gene ‘Arx’ in the vertebrate telencephalon, diencephalon and floor plate. Mech Dev 65(1–2):99–109
Shoubridge C, Fullston T, Gecz J (2010) ARX spectrum disorders: making inroads into the molecular pathology. Hum Mutat 31(8):889–900. doi:10.1002/humu.21288
Meguro T, Yoshida Y, Hayashi M, Toyota K, Otagiri T, Mochizuki N, Kishikawa Y, Sasaki A, Hayasaka K (2012) Inheritance of polyalanine expansion mutation of PHOX2B in congenital central hypoventilation syndrome. J Hum Genet 57(5):335–337. doi:jhg201227 [pii] 10.1038/jhg.2012.27
Di Zanni E, Bachetti T, Parodi S, Bocca P, Prigione I, Di Lascio S, Fornasari D, Ravazzolo R, Ceccherini I (2012) In vitro drug treatments reduce the deleterious effects of aggregates containing polyAla expanded PHOX2B proteins. Neurobiol Dis 45(1):508–518. doi:S0969-9961(11)00317-2 [pii] 10.1016/j.nbd.2011.09.007
Matera I, Bachetti T, Puppo F, Di Duca M, Morandi F, Casiraghi GM, Cilio MR, Hennekam R, Hofstra R, Schober JG, Ravazzolo R, Ottonello G, Ceccherini I (2004) PHOX2B mutations and polyalanine expansions correlate with the severity of the respiratory phenotype and associated symptoms in both congenital and late onset Central Hypoventilation syndrome. J Med Genet 41(5):373–380
Patwari PP, Carroll MS, Rand CM, Kumar R, Harper R, Weese-Mayer DE (2010) Congenital central hypoventilation syndrome and the PHOX2B gene: a model of respiratory and autonomic dysregulation. Respir Physiol Neurobiol 173(3):322–335. doi:S1569-9048(10)00231-4 [pii] 10.1016/j.resp.2010.06.013
Trochet D, Hong SJ, Lim JK, Brunet JF, Munnich A, Kim KS, Lyonnet S, Goridis C, Amiel J (2005) Molecular consequences of PHOX2B missense, frameshift and alanine expansion mutations leading to autonomic dysfunction. Hum Mol Genet 14(23):3697–3708. doi:ddi401 [pii] 10.1093/hmg/ddi401
Dauger S, Pattyn A, Lofaso F, Gaultier C, Goridis C, Gallego J, Brunet JF (2003) Phox2b controls the development of peripheral chemoreceptors and afferent visceral pathways. Development 130(26):6635–6642
Alatzoglou KS, Kelberman D, Cowell CT, Palmer R, Arnhold IJ, Melo ME, Schnabel D, Grueters A, Dattani MT (2011) Increased transactivation associated with SOX3 polyalanine tract deletion in a patient with hypopituitarism. J Clin Endocrinol Metab 96(4):E685–E690
Burkitt Wright EM, Perveen R, Clayton PE, Hall CM, Costa T, Procter AM, Giblin CA, Donnai D, Black GC (2009) X-linked isolated growth hormone deficiency: expanding the phenotypic spectrum of SOX3 polyalanine tract expansions. Clin Dysmorphol 18(4):218–221
Laumonnier F, Ronce N, Hamel BC, Thomas P, Lespinasse J, Raynaud M, Paringaux C, Van Bokhoven H, Kalscheuer V, Fryns JP, Chelly J, Moraine C, Briault S (2002) Transcription factor SOX3 is involved in X-linked mental retardation with growth hormone deficiency. Am J Hum Genet 71(6):1450–1455
Woods KS, Cundall M, Turton J, Rizotti K, Mehta A, Palmer R, Wong J, Chong WK, Al-Zyoud M, El-Ali M, Otonkoski T, Martinez-Barbera JP, Thomas PQ, Robinson IC, Lovell-Badge R, Woodward KJ, Dattani MT (2005) Over- and underdosage of SOX3 is associated with infundibular hypoplasia and hypopituitarism. Am J Hum Genet 76(5):833–849
Rizzoti K, Brunelli S, Carmignac D, Thomas PQ, Robinson IC, Lovell-Badge R (2004) SOX3 is required during the formation of the hypothalamo-pituitary axis. Nat Genet 36(3):247–255
Paulussen AD, Schrander-Stumpel CT, Tserpelis DC, Spee MK, Stegmann AP, Mancini GM, Brooks AS, Collee M, Maat-Kievit A, Simon ME, van Bever Y, Stolte-Dijkstra I, Kerstjens-Frederikse WS, Herkert JC, van Essen AJ, Lichtenbelt KD, van Haeringen A, Kwee ML, Lachmeijer AM, Tan-Sindhunata GM, van Maarle MC, Arens YH, Smeets EE, de Die-Smulders CE, Engelen JJ, Smeets HJ, Herbergs J (2010) The unfolding clinical spectrum of holoprosencephaly due to mutations in SHH, ZIC2, SIX3 and TGIF genes. Eur J Hum Genet 18(9):999–1005. doi:ejhg201070 [pii] 10.1038/ejhg.2010.70
Brown L, Paraso M, Arkell R, Brown S (2005) In vitro analysis of partial loss-of-function ZIC2 mutations in holoprosencephaly: alanine tract expansion modulates DNA binding and transactivation. Hum Mol Genet 14(3):411–420. doi:ddi037 [pii] 10.1093/hmg/ddi037
Sugawara M, Kato N, Tsuchiya T, Motoyama T (2011) RUNX2 expression in developing human bones and various bone tumors. Pathol Int 61(10):565–571. doi:10.1111/j.1440-1827.2011.02706.x
Hansen L, Riis AK, Silahtaroglu A, Hove H, Lauridsen E, Eiberg H, Kreiborg S (2011) RUNX2 analysis of Danish cleidocranial dysplasia families. Clin Genet 79(3):254–263. doi:CGE1458 [pii] 10.1111/j.1399-0004.2010.01458.x
Crisponi L, Deiana M, Loi A, Chiappe F, Uda M, Amati P, Bisceglia L, Zelante L, Nagaraja R, Porcu S, Ristaldi MS, Marzella R, Rocchi M, Nicolino M, Lienhardt-Roussie A, Nivelon A, Verloes A, Schlessinger D, Gasparini P, Bonneau D, Cao A, Pilia G (2001) The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ptosis/epicanthus inversus syndrome. Nat Genet 27(2):159–166. doi:10.1038/84781
Beysen D, De Jaegere S, Amor D, Bouchard P, Christin-Maitre S, Fellous M, Touraine P, Grix AW, Hennekam R, Meire F, Oyen N, Wilson LC, Barel D, Clayton-Smith J, de Ravel T, Decock C, Delbeke P, Ensenauer R, Ebinger F, Gillessen-Kaesbach G, Hendriks Y, Kimonis V, Laframboise R, Laissue P, Leppig K, Leroy BP, Miller DT, Mowat D, Neumann L, Plomp A, Van Regemorter N, Wieczorek D, Veitia RA, De Paepe A, De Baere E (2008) Identification of 34 novel and 56 known FOXL2 mutations in patients with blepharophimosis syndrome. Hum Mutat 29(11):E205–E219. doi:10.1002/humu.20819
Brais B, Bouchard JP, Xie YG, Rochefort DL, Chretien N, Tome FM, Lafreniere RG, Rommens JM, Uyama E, Nohira O, Blumen S, Korczyn AD, Heutink P, Mathieu J, Duranceau A, Codere F, Fardeau M, Rouleau GA (1998) Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy. Nat Genet 18(2):164–167. doi:10.1038/ng0298-164
Blumen SC, Brais B, Korczyn AD, Medinsky S, Chapman J, Asherov A, Nisipeanu P, Codere F, Bouchard JP, Fardeau M, Tome FM, Rouleau GA (1999) Homozygotes for oculopharyngeal muscular dystrophy have a severe form of the disease. Ann Neurol 46(1):115–118
Albrecht A, Mundlos S (2005) The other trinucleotide repeat: polyalanine expansion disorders. Curr Opin Genet Dev 15(3):285–293
Lavoie H, Debeane F, Trinh QD, Turcotte JF, Corbeil-Girard LP, Dicaire MJ, Saint-Denis A, Page M, Rouleau GA, Brais B (2003) Polymorphism, shared functions and convergent evolution of genes with sequences coding for polyalanine domains. Hum Mol Genet 12(22):2967–2979
Karlin S, Chen C, Gentles AJ, Cleary M (2002) Associations between human disease genes and overlapping gene groups and multiple amino acid runs. Proc Natl Acad Sci USA 99(26):17008–17013. doi:10.1073/pnas.262658799262658799 [pii]
Mojsin M, Kovacevic-Grujicic N, Krstic A, Popovic J, Milivojevic M, Stevanovic M (2010) Comparative analysis of SOX3 protein orthologs: expansion of homopolymeric amino acid tracts during vertebrate evolution. Biochem Genet 48(7–8):612–623. doi:10.1007/s10528-010-9343-2
Giri K, Bhattacharyya NP, Basak S (2007) pH-dependent self-assembly of polyalanine peptides. Biophys J 92(1):293–302. doi:S0006-3495(07)70827-5 [pii] 10.1529/biophysj.106.091769
Shinchuk LM, Sharma D, Blondelle SE, Reixach N, Inouye H, Kirschner DA (2005) Poly-(L-alanine) expansions form core beta-sheets that nucleate amyloid assembly. Proteins 61(3):579–589. doi:10.1002/prot.20536
Nguyen HD, Hall CK (2004) Molecular dynamics simulations of spontaneous fibril formation by random-coil peptides. Proc Natl Acad Sci USA 101(46):16180–16185. doi:0407273101 [pii] 10.1073/pnas.0407273101
Nojima J, Oma Y, Futai E, Sasagawa N, Kuroda R, Turk B, Ishiura S (2009) Biochemical analysis of oligomerization of expanded polyalanine repeat proteins. J Neurosci Res 87(10):2290–2296. doi:10.1002/jnr.22052
Rankin J, Wyttenbach A, Rubinsztein DC (2000) Intracellular green fluorescent protein-polyalanine aggregates are associated with cell death. Biochem J 348(Pt 1):15–19
Albrecht AN, Kornak U, Boddrich A, Suring K, Robinson PN, Stiege AC, Lurz R, Stricker S, Wanker EE, Mundlos S (2004) A molecular pathogenesis for transcription factor associated poly-alanine tract expansions. Hum Mol Genet 13(20):2351–2359
Bachetti T, Matera I, Borghini S, Di Duca M, Ravazzolo R, Ceccherini I (2005) Distinct pathogenetic mechanisms for PHOX2B associated polyalanine expansions and frameshift mutations in congenital central hypoventilation syndrome. Hum Mol Genet 14(13):1815–1824. doi:ddi188 [pii] 10.1093/hmg/ddi188
Caburet S, Demarez A, Moumne L, Fellous M, De Baere E, Veitia RA (2004) A recurrent polyalanine expansion in the transcription factor FOXL2 induces extensive nuclear and cytoplasmic protein aggregation. J Med Genet 41(12):932–936. doi:41/12/932 [pii] 10.1136/jmg.2004.024356
Nasrallah IM, Minarcik JC, Golden JA (2004) A polyalanine tract expansion in Arx forms intranuclear inclusions and results in increased cell death. J Cell Biol 167(3):411–416
Wong J, Farlie P, Holbert S, Lockhart P, Thomas PQ (2007) Polyalanine expansion mutations in the X-linked hypopituitarism gene SOX3 result in aggresome formation and impaired transactivation. Front Biosci 12:2085–2095
Abu-Baker A, Messaed C, Laganiere J, Gaspar C, Brais B, Rouleau GA (2003) Involvement of the ubiquitin-proteasome pathway and molecular chaperones in oculopharyngeal muscular dystrophy. Hum Mol Genet 12(20):2609–2623. doi:10.1093/hmg/ddg293 ddg293 [pii]
Hartl FU, Hayer-Hartl M (2002) Molecular chaperones in the cytosol: from nascent chain to folded protein. Science 295(5561):1852–1858. doi:10.1126/science.1068408 295/5561/1852 [pii]
Villavicencio-Lorini P, Kuss P, Friedrich J, Haupt J, Farooq M, Turkmen S, Duboule D, Hecht J, Mundlos S (2010) Homeobox genes d11-d13 and a13 control mouse autopod cortical bone and joint formation. J Clin Invest 120(6):1994–2004. doi:41554 [pii] 10.1172/JCI41554
Raz V, Abraham T, van Zwet EW, Dirks RW, Tanke HJ, van der Maarel SM (2011) Reversible aggregation of PABPN1 pre-inclusion structures. Nucleus 2(3):208–218. doi:10.4161/nucl.2.3.15736 1949-1034-2-3-8 [pii]
Tavanez JP, Calado P, Braga J, Lafarga M, Carmo-Fonseca M (2005) In vivo aggregation properties of the nuclear poly(A)-binding protein PABPN1. RNA 11(5):752–762
Jenal M, Elkon R, Loayza-Puch F, van Haaften G, Kuhn U, Menzies FM, Oude Vrielink JA, Bos AJ, Drost J, Rooijers K, Rubinsztein DC, Agami R (2012) The poly(A)-binding protein nuclear 1 suppresses alternative cleavage and polyadenylation sites. Cell 149(3):538–553. doi:S0092-8674(12)00398-4 [pii] 10.1016/j.cell.2012.03.022
Davies JE, Sarkar S, Rubinsztein DC (2008) Wild-type PABPN1 is anti-apoptotic and reduces toxicity of the oculopharyngeal muscular dystrophy mutation. Hum Mol Genet 17(8):1097–1108. doi:ddm382 [pii] 10.1093/hmg/ddm382
Bruneau S, Johnson KR, Yamamoto M, Kuroiwa A, Duboule D (2001) The mouse Hoxd13(spdh) mutation, a polyalanine expansion similar to human type II synpolydactyly (SPD), disrupts the function but not the expression of other Hoxd genes. Dev Biol 237(2):345–353
Poirier K, Eisermann M, Caubel I, Kaminska A, Peudonnier S, Boddaert N, Saillour Y, Dulac O, Souville I, Beldjord C, Lascelles K, Plouin P, Chelly J, Bahi-Buisson N (2008) Combination of infantile spasms, non-epileptic seizures and complex movement disorder: a new case of ARX-related epilepsy. Epilepsy Res 80(2–3):224–228. doi:S0920-1211(08)00085-5 [pii] 10.1016/j.eplepsyres.2008.03.019
Kitamura K, Itou Y, Yanazawa M, Ohsawa M, Suzuki-Migishima R, Umeki Y, Hohjoh H, Yanagawa Y, Shinba T, Itoh M, Nakamura K, Goto Y (2009) Three human ARX mutations cause the lissencephaly-like and mental retardation with epilepsy-like pleiotropic phenotypes in mice. Hum Mol Genet 18(19):3708–3724
Price MG, Yoo JW, Burgess DL, Deng F, Hrachovy RA, Frost JD Jr, Noebels JL (2009) A triplet repeat expansion genetic mouse model of infantile spasms syndrome, Arx(GCG)10 + 7, with interneuronopathy, spasms in infancy, persistent seizures, and adult cognitive and behavioral impairment. J Neurosci 29(27):8752–8763
Collombat P, Mansouri A, Hecksher-Sorensen J, Serup P, Krull J, Gradwohl G, Gruss P (2003) Opposing actions of Arx and Pax4 in endocrine pancreas development. Genes Dev 17(20):2591–2603. doi:10.1101/gad.269003 17/20/2591 [pii]
Kitamura K, Yanazawa M, Sugiyama N, Miura H, Iizuka-Kogo A, Kusaka M, Omichi K, Suzuki R, Kato-Fukui Y, Kamiirisa K, Matsuo M, Kamijo S, Kasahara M, Yoshioka H, Ogata T, Fukuda T, Kondo I, Kato M, Dobyns WB, Yokoyama M, Morohashi K (2002) Mutation of ARX causes abnormal development of forebrain and testes in mice and X-linked lissencephaly with abnormal genitalia in humans. Nat Genet 32(3):359–369. doi:10.1038/ng1009 ng1009 [pii]
Amiel J, Dubreuil V, Ramanantsoa N, Fortin G, Gallego J, Brunet JF, Goridis C (2009) PHOX2B in respiratory control: lessons from congenital central hypoventilation syndrome and its mouse models. Respir Physiol Neurobiol 168(1–2):125–132. doi:S1569-9048(09)00060-3 [pii] 10.1016/j.resp.2009.03.005
Benailly HK, Lapierre JM, Laudier B, Amiel J, Attie T, De Blois MC, Vekemans M, Romana SP (2003) PMX2B, a new candidate gene for Hirschsprung’s disease. Clin Genet 64(3):204–209. doi:105 [pii]
Dubreuil V, Ramanantsoa N, Trochet D, Vaubourg V, Amiel J, Gallego J, Brunet JF, Goridis C (2008) A human mutation in Phox2b causes lack of CO2 chemosensitivity, fatal central apnea, and specific loss of parafacial neurons. Proc Natl Acad Sci USA 105(3):1067–1072
Ramanantsoa N, Hirsch MR, Thoby-Brisson M, Dubreuil V, Bouvier J, Ruffault PL, Matrot B, Fortin G, Brunet JF, Gallego J, Goridis C (2011) Breathing without CO(2) chemosensitivity in conditional Phox2b mutants. J Neurosci 31(36):12880–12888. doi:31/36/12880 [pii] 10.1523/JNEUROSCI.1721-11.2011
Di Zanni E, Bachetti T, Parodi S, Bocca P, Prigione I, Di Lascio S, Fornasari D, Ravazzolo R, Ceccherini I (2011) In vitro drug treatments reduce the deleterious effects of aggregates containing polyAla expanded PHOX2B proteins. Neurobiol Dis 45(1):508–518. doi:S0969-9961(11)00317-2 [pii] 10.1016/j.nbd.2011.09.007
Davies JE, Wang L, Garcia-Oroz L, Cook LJ, Vacher C, O’Donovan DG, Rubinsztein DC (2005) Doxycycline attenuates and delays toxicity of the oculopharyngeal muscular dystrophy mutation in transgenic mice. Nat Med 11(6):672–677. doi:nm1242 [pii] 10.1038/nm1242
Davies JE, Sarkar S, Rubinsztein DC (2006) Trehalose reduces aggregate formation and delays pathology in a transgenic mouse model of oculopharyngeal muscular dystrophy. Hum Mol Genet 15(1):23–31. doi:ddi422 [pii] 10.1093/hmg/ddi422
Dolle P, Dierich A, LeMeur M, Schimmang T, Schuhbaur B, Chambon P, Duboule D (1993) Disruption of the Hoxd-13 gene induces localized heterochrony leading to mice with neotenic limbs. Cell 75(3):431–441. doi:0092-8674(93)90378-4 [pii]
Fromental-Ramain C, Warot X, Messadecq N, LeMeur M, Dolle P, Chambon P (1996) Hoxa-13 and Hoxd-13 play a crucial role in the patterning of the limb autopod. Development 122(10):2997–3011
Beguin S, Crepel V, Aniksztejn L, Becq H, Pelosi B, Pallesi-Pocachard E, Bouamrane L, Pasqualetti M, Kitamura K, Cardoso C, Represa A (2012) An epilepsy-related ARX polyalanine expansion modifies glutamatergic neurons excitability and morphology without affecting GABAergic neurons development. Cereb Cortex. doi:bhs138 [pii] 10.1093/cercor/bhs138
Nasrallah MP, Cho G, Simonet JC, Putt ME, Kitamura K, Golden JA (2012) Differential effects of a polyalanine tract expansion in Arx on neural development and gene expression. Hum Mol Genet 21(5):1090–1098. doi:ddr538 [pii] 10.1093/hmg/ddr538
Warr N, Powles-Glover N, Chappell A, Robson J, Norris D, Arkell RM (2008) Zic2-associated holoprosencephaly is caused by a transient defect in the organizer region during gastrulation. Hum Mol Genet 17(19):2986–2996. doi:ddn197 [pii] 10.1093/hmg/ddn197
Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, Shimizu Y, Bronson RT, Gao YH, Inada M, Sato M, Okamoto R, Kitamura Y, Yoshiki S, Kishimoto T (1997) Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89(5):755–764. doi:S0092-8674(00)80258-5 [pii]
Otto F, Thornell AP, Crompton T, Denzel A, Gilmour KC, Rosewell IR, Stamp GW, Beddington RS, Mundlos S, Olsen BR, Selby PB, Owen MJ (1997) Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89(5):765–771. doi:S0092-8674(00)80259-7 [pii]
Uda M, Ottolenghi C, Crisponi L, Garcia JE, Deiana M, Kimber W, Forabosco A, Cao A, Schlessinger D, Pilia G (2004) Foxl2 disruption causes mouse ovarian failure by pervasive blockage of follicle development. Hum Mol Genet 13(11):1171–1181. doi:10.1093/hmg/ddh124 ddh124 [pii]
Hughes J, Piltz S, Rogers N, McAninch D, Rowley L, Thomas P (2013) Mechanistic insight into the pathology of polyalanine expansion disorders revealed by a mouse model for x linked hypopituitarism. PLoS Genet. 9(3):e1003290. doi:10.1371/journal.pgen.1003290. Epub 2013 Mar 7
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media, New York
About this protocol
Cite this protocol
Hughes, J.N., Thomas, P.Q. (2013). Molecular Pathology of Polyalanine Expansion Disorders: New Perspectives from Mouse Models. In: Hatters, D., Hannan, A. (eds) Tandem Repeats in Genes, Proteins, and Disease. Methods in Molecular Biology, vol 1017. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-438-8_10
Download citation
DOI: https://doi.org/10.1007/978-1-62703-438-8_10
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-437-1
Online ISBN: 978-1-62703-438-8
eBook Packages: Springer Protocols